Via Nova Therapeutics is committed to discovering novel therapies for viral diseases, especially those arising from acute & subacute infections, and to pioneer sustainable business strategies to deliver these treatments to the clinic.
No named decision-maker yet.
Careers mailbox is known
Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell engager.
No named decision-maker yet.
Careers mailbox is known
Jun 24
Raised a round Series B $62M
How many of the open roles read as an active search right now, by the liveness score every vacancy carries: board confirmation, hiring activity, room left.%d roles posted in the last 7 days.Median days from posting to closing over %1$d roles closed on this board. The market figure is the median for its main sphere, %2$s, across every company.Average stated annual pay, in USD, across the %d open roles that publish one.Truth index %s: ghost roles %d%%, stale roles %d%%, reposted %d%%, over %d open roles.
